首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF SALBUTAMOL SULFATE FOR THE CHRONOTHERAPY OF ASTHMA
【24h】

FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF SALBUTAMOL SULFATE FOR THE CHRONOTHERAPY OF ASTHMA

机译:硫酸沙丁胺醇多功能药物输送系统的研制与评价。

获取原文
获取外文期刊封面目录资料

摘要

Objective: The main objective of the present study was to design and evaluate a time-controlled single unit oral pulsatile drug delivery system containing salbutamol sulfate for the prevention of nocturnal asthma attacks. Methods: Drug containing core tablets (C1-C10) with different composition of superdisintegrants such as sodium starch glycolate, croscarmellose sodium, and crospovidone were prepared by direct compression technique. The fast disintegrating core tablet formulation was selected, and press-coated tablets (P1-P11) were prepared with different compositions of hydrophobic and hydrophilic polymers: Ethylcellulose-20 (EC-20), hydroxypropyl methylcellulose K4M, and low substituted hydroxypropyl cellulose (L-HPC LH11). The coating polymers were selected and quantified based on in vitro lag time and drug release profile in simulated gastric and intestinal fluids. Results: Formulation C10 with 7.5% crospovidone showed least disintegrating time, i.e., 0.31 min and was selected as the best immediate release core tablet. The press-coated tablet formulation P11 having 360 mg barrier layer of EC-20 and L-HPC LH11 in ratio 14:1 over the core tablet C10 showed rapid and complete drug release nearly after 6 h lag time. Accelerated stability studies of the optimized formulation P11 indicated no significant difference in release profile after a period of 6 months. Conclusion: The in vitro dissolution study showed that lag time before drug release was highly affected by the coating level and nature of coating polymer used. Time-controlled pulsatile release tablets can be prepared using press-coating techniques.
机译:目的:本研究的主要目的是设计和评估一种含硫酸沙丁胺醇的时间控制的单单位口服脉动药物递送系统,以预防夜间哮喘发作。方法:采用直接压片技术,制备了不同成分的超崩解剂(如乙醇酸淀粉钠,交联羧甲基纤维素钠和交联维酮)的含药核心片剂(C1-C10)。选择了快速崩解的核心片剂配方,并制备了具有不同疏水性和亲水性聚合物成分的压制片剂(P1-P11):乙基纤维素20(EC-20),羟丙基甲基纤维素K4M和低取代羟丙基纤维素(L -HPC LH11)。根据体外滞后时间和模拟胃液和肠液中的药物释放曲线,选择并定量涂层聚合物。结果:具有7.5%交联聚维酮的制剂C10崩解时间最短,即0.31分钟,并被选为最佳速释核心片剂。在核心片剂C10上具有比例为14:1的EC-20和L-HPC LH11的360 mg阻隔层的压制片剂制剂P11几乎在滞后6小时后显示出快速而完全的药物释放。优化配方P11的加速稳定性研究表明,经过6个月后,释放曲线没有显着差异。结论:体外溶出研究表明,药物释放前的滞后时间受涂料水平和所用涂料聚合物性质的影响很大。可以使用压力包衣技术制备时间控制的脉冲释放片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号